Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 386 | 782 | 1,313 | 3 | 0 |
| TOTAL | $411 | $801 | $1,333 | $115 | $33 |
| Non-Current Assets | |||||
| PPE Net | 4 | 5 | 2 | 2,219 | 3 |
| Other Non-Current Assets | 152 | 169 | 7 | 13 | 0 |
| TOTAL | $156 | $174 | $9 | $2,232 | $3 |
| Total Assets | $567 | $975 | $1,342 | $130 | $35 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 746 | 662 | 822 | 1,040 | 967 |
| Accrued Expenses | 3,129 | 3,055 | 2,982 | 2,890 | 2,797 |
| Other current liabilities | 521 | 591 | 651 | 690 | 725 |
| TOTAL | $5,027 | $4,927 | $4,745 | $4,903 | $4,763 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26 | 26 | 275 | 246 | 122 |
| Other Non-Current Liabilities | 128 | 141 | 28 | 19 | 16 |
| TOTAL | $108 | $127 | $275 | $246 | $122 |
| Total Liabilities | $5,135 | $5,054 | $5,019 | $5,148 | $4,885 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,932 | 64,932 | 64,932 | 64,932 | 49,622 |
| Common Shares | 4 | 3 | 2 | 601 | 601 |
| Retained earnings | -119,430 | -118,987 | -118,626 | -119,062 | -118,912 |
| Other shareholders' equity | -693 | -647 | -606 | -579 | -560 |
| TOTAL | $-4,568 | $-4,079 | $-3,677 | $-5,019 | $-4,850 |
| Total Liabilities And Equity | $567 | $975 | $1,342 | $130 | $35 |